Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 71% · refreshes every 15s during session
ABVC BIOPHARMA, INC. shows accelerating business momentum based on AlphaOS pipeline evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 22d ago
ABVC's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on ABVC.
Free accounts see more of this; Premium sees all of it.
Reported figures for ABVC BIOPHARMA, INC. — research only, not investment advice.
Updated
What happened recently for ABVC BIOPHARMA, INC. (ABVC) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
ABVC's AI investment thesis
Upgrade to Premium for ABVC's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Latest price
$1.05
Market cap
$27.99M
Profitable
No
Revenue $795,950.00
Net income
$-2.04M
FY Sep 15, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for ABVC BIOPHARMA, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow ABVC BIOPHARMA, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.